Leiomyosarcoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Leiomyosarcoma}} | {{Leiomyosarcoma}} | ||
{{CMG}};{{AE}} | {{CMG}};{{AE}}{{Nnasiri}} | ||
== Overview: == | == Overview: == | ||
There are no specific laboratory findings associated with leiomyosarcoma, patients may have low [[hemoglobin]] and [[Red blood cell|red blood cells]] on their complete blood count, immunohistochemistry markers can be positive but non-diagnostics. | There are no specific laboratory findings associated with leiomyosarcoma, patients may have low [[hemoglobin]] and [[Red blood cell|red blood cells]] on their complete blood count, immunohistochemistry markers can be positive but non-diagnostics. | ||
Latest revision as of 15:57, 4 April 2019
|
Leiomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Leiomyosarcoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Leiomyosarcoma laboratory tests |
|
Risk calculators and risk factors for Leiomyosarcoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview:
There are no specific laboratory findings associated with leiomyosarcoma, patients may have low hemoglobin and red blood cells on their complete blood count, immunohistochemistry markers can be positive but non-diagnostics.
Lab test:
- There are no specific laboratory findings associated with leiomyosarcoma.
- Elevated levels of CA-125 and LDH( isozymes) in women with uterine sarcoma, the usefulness of these markers are still being investigated.
- There are immunohistochemistry markers associated with sarcoma but it can be positive in any other soft tissue tumors, some of these markers are include:[1][2][3]
References
- ↑ R, Stramare; G, Orsatti (2016). "Imaging Features, Differential Diagnosis and Management of Leiomyosarcomas: Case Series and Review of the Literature". Journal of Cancer Science & Therapy. 08 (04). doi:10.4172/1948-5956.1000397. ISSN 1948-5956.
- ↑ Goto A, Takeuchi S, Sugimura K, Maruo T (2002) Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 12 (4):354-61. PMID: 12144683
- ↑ Hoskins PJ, Le N (2008) Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus. Int J Gynecol Cancer 18 (6):1200-1. DOI:10.1111/j.1525-1438.2007.01187.x PMID: 18217961